RPL26P31

Across TCGA pan-cancer cohorts, RPL26P31 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RPL26P31 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RPL26P31 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL26P31 expression acts as an unfavorable survival marker, although some lineages such as LIHC show a favorable association.

UVM, KICH, and THYM are the cancer types where RPL26P31 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.244	0.866	<.001	126	view →
KICH	DFS	Tertile	All	0.079	0.891	<.001	84	view →
THYM	OS	Tertile	III,IV	0.229	1.000	<.001	45	view →
ACC	OS	Tertile	All	0.133	0.631	.017	45	view →
OV	DFS	Quartile	IV	0.244	0.514	.002	40	view →
READ	OS	Tertile	III,IV	0.644	0.932	<.001	33	view →
MESO	OS	Tertile	All	0.130	0.557	.019	27	view →
BLCA	DFS	Tertile	III,IV	0.363	0.584	.021	24	view →
CHOL	DFS	Tertile	All	0.037	0.486	.001	18	view →
KIRC	DFS	Tertile	All	0.401	0.659	.008	12	view →
GBM	OS	Tertile	All	0.255	0.455	.025	9	view →
LIHC	OS	Tertile	All	1.000	0.767	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RPL26P31–UVM (OS)

Open the UVM breakdown →